Drug intelligence / Profile preview

Tangweian Recipe

Development stage: Phase 2
Lead developer: Guang'anmen Hospital
Administration: Oral

Overview

Tangweian Recipe is a Chinese Herbal Medicine specifically developed for the treatment of Diabetic Gastroparesis (DGP). It is indicated for patients diagnosed with diabetes mellitus combined with gastroenteropathy, particularly those exhibiting spleen and stomach disharmony according to Traditional Chinese Medicine principles. Clinical trials are underway to assess its efficacy and safety, often in comparison to or in combination with conventional treatments like mosapride citrate tablets.

Other names: TWA

Beyond the preview

Go deeper on Tangweian Recipe.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tangweian Recipe.

Explore the full profile